as per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals reported strong FY25 results with standalone revenue from operations rising ~12.8% to Rs.8,202 crore and profit after tax up ~28.3% to Rs.1,296 crore (EPS of Rs.90.15 vs Rs.70.28). On a consolidated basis, revenue grew ~14.3% to Rs.21,794 crore and PAT jumped ~61% to Rs.1,505 crore (EPS Rs.100.56 vs Rs.62.50). EBITDA stood at Rs.2,044 crore standalone and Rs.2,442 crore consolidated. The Board recommended a final dividend of Rs.10/share (200%), taking total FY25 dividend to Rs.19/share (380%), worth Rs.273 crore. The Board also approved acquisition of an existing 200-bed hospital for Rs.285 crore, re-appointment of executive directors and independent director Som Mittal, and appointment of new secretarial auditors. Credit rating reaffirmed at AA+/Stable by CRISIL and India Ratings. Auditor Deloitte Haskins & Sells LLP gave an unmodified opinion.
Strong earnings growth, especially on consolidated basis, and a healthy total dividend payout of Rs.19/share are positive for shareholders. The hospital acquisition signals continued expansion, while the strong credit rating (AA+) and unmodified audit opinion reinforce financial stability.